Copyright Reports & Markets. All rights reserved.

Anti-Diabetic Pharmaceuticals Market in India 2019

Buy now

Slide 1: Executive Summary

    Macroeconomic Indicators

      Slide 2: GDP at Factor Cost: Quarterly (2011-12 - 2014-15), Inflation Rate: Monthly (Dec 2014-Jan 2015 - Mar 2015-Apr 2015)

        Slide 3: Gross Fiscal Deficit: Monthly (Feb 2014 - Jul 2014), Exchange Rate: Monthly (Dec 2014 - May 2015)

          Slide 4: Lending Rate: Annual (2011-12 - 2014-15), Trade Balance: Annual (2011-12 - 2014-15), FDI: Annual (2009-10 - 2013-14)

            Introduction

              Slide 5: Types of diabetes

                Slide 6: Classification of the diabetes market

                  Slide 7: Classes of anti-diabetic drugs

                    Market Overview

                      Slide 8: Global Anti-Diabetic Pharmaceuticals Market - Overview, Size & Growth

                        Slide 9: Indian Anti-Diabetic Pharmaceuticals Market - Overview, Size & Growth

                          Slide 10: Global Diabetes map

                            Drivers & Challenges

                              Slide 11: Summary

                                Slide 12-15: Key Drivers

                                  Slide 16-17: Key Challenges

                                    Government Initiatives

                                      Slide 18: Government programmes

                                        Market Value Chain

                                          Slide 19: Pharmaceutical Value Chain

                                            Slide 20: Multistage Drug Development Process

                                              Regulation and Patents

                                                Slide 21: Drug regulations

                                                  Slide 22-23: Drugs approved for marketing in India

                                                    Slide 24: Regulatory Frameworks

                                                      Competitive Landscape

                                                        Slide 25: Competition Overview

                                                          Slide 26: Porter's Five Forces Analysis

                                                            Slide 27-31: Competitive benchmarking

                                                              Slide 32-71: Major Public Player

                                                                Strategic Recommendations

                                                                  Slide 72: Key Strategic Recommendations

                                                                    Appendix

                                                                      Slide 73: Appendix

                                                                        Slide 74: Sources of information

                                                                        Anti-diabetic pharmaceuticals market in India is considered to be one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world, after China, the market is characterized by a huge demand for anti-diabetic drugs. Huge increase in the number of diabetic patients promotes growth of the anti-diabetics pharmaceutical industry. The incidence of diabetes is higher in developed countries because of unhealthy lifestyles . Development of new and innovative drugs is also providing a boost to the market. Comprehensive health insurance coverage fuels the market growth by raising the affordability among patients. Increasing aging population in India increases the prevalence of diabetes, which in turn gives a boost to the drugs market.
                                                                        However Price regulation in the insulin market and competition from alternative diabetes treatment hinders the growth of Anti-diabetic pharmaceuticals market in India. In spite of substantial demand-supply gap in the insulin market, foreign manufacturers and importers are facing a huge price challenge. Now-a-days People are becoming more aware of diabetes ,and are trying to move away from unhealthy sedentary lifestyles. Increasing awareness on part of the consumers are making them incorporate more physical exercises and avoid junk food. Such consciousness on part of the consumers is decreasing the growth of diabetes, which is limiting the growth of the anti-diabetic pharmaceutical market to some extent. The Indian Government, on its part, has introduced some diabetes control programmes. Various initiatives taken by the government is providing a boost to this market. The market is expected to exhibit steady growth over the next few years.

                                                                        Buy now